Nasdaq

Corbus Pharma Starts Multiple Ascending Dose Phase 1 Study Of CRB-913 For Obesity Treatment

(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), announced Monday the initiation of the multiple ascending dose or MAD portion of its Phase 1 clinical trial evaluating CRB-913, a highly ...
KRQE Blogs

atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)

The PK profile of EMP-01 was dose-proportional, and a range of exploratory pharmacodynamic (PD) measures, including subjective reports and blood-based biomarkers, showed dose-dependent changes EMP-01 ...
Hosted on MSN

Cero doses third patient in starting dose cohort of Phase 1 CER-1236 trial

CERo Therapeutics (CERO) dosed the third patient in the starting dose cohort of its Phase 1 clinical trial evaluating CER-1236 in acute myeloid leukemia. Per protocol, three patients are planned at ...
Nasdaq

CytomX Therapeutics Doses First Patient in Phase 1 Study of CX-801 Combined with KEYTRUDA® for Metastatic Melanoma

CytomX Therapeutics dosed the first patient with CX-801 combined with KEYTRUDA® in a Phase 1 study for metastatic melanoma. CytomX Therapeutics has announced the dosing of the first patient in a Phase ...